Table 5

Number and sites of metastases and time taken for metastases to develop in 'basal' versus 'non-basal' tumours

Site of metastasis

Number

5-year proportion free of metastases

Hazard ratio

p value


Basal

Non-basal

Basal

Non-basal

(95% CI)


All sites

No

51

169

59%

55%

0.65 (0.48–0.88)

0.005

Yes

37

186

Bone

No

74

245

85%

73%

0.49 (0.28–0.86)

0.01

Yes

14

109

Liver

No

76

265

86%

77%

0.53 (0.29–0.97)

0.035

Yes

12

89

Brain

No

75

327

85%

93%

1.92 (0.27–1.01)

0.051

Yes

13

27

Lung/pleura

No

65

261

73%

77%

0.92 (0.58–1.46)

0.72

Yes

23

93

Skin

No

79

316

87%

90%

0.94 (0.45–1.95)

0.87

Yes

9

38

Pericardial/mediastinum

No

84

342

94%

97%

1.23 (0.39–3.83)

0.72

Yes

4

12

Nodes (non-regional)

No

83

293

93%

84%

0.31 (0.13–0.78)

0.008

Yes

5

61


CI, confidence interval.

Fulford et al. Breast Cancer Research 2007 9:R4   doi:10.1186/bcr1636

Open Data